Articles related to Internal Medicine

The Wegovy tablet is the first oral GLP-1 receptor agonist indicated for weight loss and cardiovascular risk reduction in eligible adults.

This case highlights how Rapunzel syndrome may masquerade as a functional or sensory feeding disorder and emphasizes the value of magnetic resonance enterography as a radiation-free diagnostic modality in pediatric patients with unexplained weight loss.

“Not all time-restricted eating patterns are equal. Eating earlier appears to confer broader metabolic advantages compared with delaying food intake to later hours.” — Ling-Wei Chen, PhD, National Taiwan University

“Hair loss can be very debilitating. We should start thinking about more proactive strategies to mitigate risks.” — Yagiz Matthew Akiska, MD/MPH candidate, George Washington University

“Patients hospitalized for HFrEF in US clinical practice are at very high risk of poor clinical outcomes, even when prescribed quadruple medical therapy.” — Dr. Stephen J. Greene, Duke Clinical Research Institute

“Relying on spot serum lactate as a marker for poor perfusion leads to incorrect and harmful interventions, particularly fluid overload.” — Dr. Frank Brodkey